Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)

Author： Boni C.   Savoldi L.   Bisagni G.   Ceci G.   Crino L.   De Lisi V.   Di Costanzo F.   Lasagni L.   Manenti A.L.   Moretti G.   Rondini E.   Sassi M.   Zadro A.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.12, 1998-11, pp. : 1974-1976

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

By Paccagnella A.   Favaretto A.   Oniga F.   Barbieri F.   Ceresoli G.   Torri W.   Villa E.   Verusio C.   Cetto G.L.   Santo A.   De Pangher V.   Artioli F.   Cacciani G.C.   Parodi G.   Soresi F.   Ghi M.G.   Morabito A.   Biason R.   Giusto M.   Mosconi P.   Chiarion Sileni V.   GSTPV Gruppo di Studio Tumori Polmonari del Veneto  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 83-91

Elsevier

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial

By Krajnik G.   Wein W.   Greil R.   Marhold F.   Mohn-Staudner A.   Kummer F.   Malayeri R.   Zochbauer-Muller S.   Huber H.   Pirker R.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1977-1980

Elsevier

Access to resources Recommend Favorite

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

By Casal Rubio J.   Fírvida-Pérez J.   Lázaro-Quintela M.   Barón-Duarte F.   Alonso-Jáudenes G.   Santomé L.   Afonso-Afonso F.   Amenedo M.   Huidobro G.   Campos-Balea B.   López-Vázquez M.   Vázquez S.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 451-457

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

By Kontopodis Emmanouil  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 49-55

Maney Publishing

Access to resources Recommend Favorite